With all the stimulus money getting tossed around these days, you’d figure biotechnology would be near the top of the wish list.
Instead, specific funding for early stage science companies was practically written out of the $780 billion package, claims the president of Madison-based Centrose LLC.
A line inserted into the massive spending bill says $10 billion in stimulus funds provided to the National Institutes of Health are exempt from a previous requirement that 2.5 percent of NIH research money go to private companies.